Clinical features of patients included in the study
| Number of patients receiving BMT by number of remissions and disease: | |
|---|---|
| In first complete remission | |
| ALL | 9 |
| AML | 14 |
| CML | 5 |
| In second and third complete remission | |
| ALL | 16 |
| AML | 8 |
| Number of patients by number of remissions and type of transplant: | |
| In first complete remission | |
| Autologous BMT | 10 |
| Allogeneic BMT | 18 |
| In second and third complete remission | |
| Autologous BMT | 9 |
| Allogeneic BMT | 15 |
| Number of patients with GVHD: | |
| Acute | 25 |
| Chronic | 8 |
| Number of patients with HCMV reactivation | 7 |
| Number of patients with pulmonary infection | 8 |
BMT = bone marrow transplantation; ALL = acute lymphoblastic leukaemia; AML = acute myelogeneous leukaemia; CML = chronic myelogeneous leukaemia; GVHD = graft versus host disease; HCMV = human cytomegalovirus.